Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone Receive Ethical, Regulatory Approval From Georgia For Clinical Phase 2B Study In RA

Feb 10 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE RECEIVE ETHICAL AND REGULATORY APPROVAL FROM
GEORGIA TO
CONDUCT CLINICAL PHASE 2B STUDY IN RA

Source text for Eikon:  ID:nWkr5q6GBx 
Further company coverage:  CYXO.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Cyxone AB

See all news